Author

Annamaria De Pellegrin

Observed name: AnnaMaria De Pellegrin

Observed institutions: University of Padua, Ospedale Civile di Vittorio Veneto

OpenAlex ID: A5083204537

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 315

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

2021 · Gregory G. Schwartz, Gregory G. Schwartz, et al. · Journal of the American College of Cardiology · 148

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 118

Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia

2013 · Harold E. Bays, Maurizio Averna, et al. · The American Journal of Cardiology · 50

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40

Cytokine Network in Chronic Perianal Crohn’s Disease and Indeterminate Colitis After Colectomy

2007 · Cesare Ruffolo, Marco Scarpa, et al. · Journal of Gastrointestinal Surgery · 27

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES

2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 26

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 25

Ezetimibe & Atorvastatin Coadministration vs Atorvastatin Uptitration or Switching to Rosuvastatin in Primary Hypercholesterolemic Patients at High Cardiovascular Risk

2013 · Harold E. Bays, Maurizio Averna, et al. · Journal of clinical lipidology

Role of ANCA in necrotizing vasculitis and in chronic inflammatoryintestinal disease

2008 · Annamaria De Pellegrin · Padua Research Archive (University of Padova)

Acute myocarditis after steroid withdrawal in an asthmatic patient

2007 · Elena Ossi, Claudio Bilato, et al. · World Allergy Organization Journal

Works count: 11

Citation count: 748

H-index: 8

I10-index: 8